Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new build/version of the study history page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the study history, replacing the previous 'Revision: v3.6.2'. This reflects an updated platform release recorded in the version history.SummaryDifference0.0%

- Check39 days agoChange DetectedA new history entry was added for 2026-06-26 indicating a Study Status update with version 142 and Revision: v3.6.2, and an earlier 2026-02-20 entry as well as Revision: v3.6.0 were removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record now shows that the study is not enrolling participants, and the history includes a new revision (v3.6.0) replacing the prior revision (v3.5.5).SummaryDifference0.1%

- Check61 days agoChange DetectedThe history now includes a new latest revision tag v3.5.5, while the previous revision v3.5.4 is removed from the list.SummaryDifference0.0%

- Check82 days agoChange DetectedThe history now shows a new site revision, v3.5.4, replacing the prior v3.5.3. This indicates a small update to the page's release notes in the history log.SummaryDifference0.0%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.